好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Event Related Potentials as a possible Traumatic Brain Injury (TBI) biomarker in older patients at risk of neurodegenerative disorders
Aging, Dementia, and Behavioral Neurology
P2 - Poster Session 2 (5:30 PM-6:30 PM)
9-017

Our study examined how Event Related Potentials (ERPs) may be a potential biomarker for a history of Traumatic Brain Injury (TBI). 

Given a current lack of research on TBI biomarkers and on the ERP signatures of TBI, identifying a biomarker may allow clinicians to improve the diagnostic accuracy of TBI. It is also possible that putative TBI biomarkers may have implications for the detection of neurodegenerative diseases including CTE.

A three-tone auditory oddball task using an eight electrodes COGNISION™ rig was used in 137 participants from a memory disorders clinic with and without a history of TBI based on chart review and self-report. 

Our results showed that both P50 standard and target latencies were significantly different between the TBI and non TBI groups (p < 0.005 and p < 0.05). Both P50 target and standard latencies showed longer latencies in the TBI group. By performing two logistic regressions, we also found that both P50 latencies are significant predictors for the presence or absence of TBI.

P50 has been previously used to examine the ability of the brain to inhibit irrelevant sensory inputs, reflecting a preattentional inhibitory mechanism that could be protecting higher order cognitive functions. Our results, showing significant greater latency, are consistent with the idea that individuals with TBI have impaired preattentional inhibitory control.

Authors/Disclosures
Katherine Turk, MD (Boston VA)
PRESENTER
The institution of Dr. Turk has received research support from Alzheimer's Association. The institution of Dr. Turk has received research support from US Department of Veterans Affairs.
Anna Marin (Boston University School of Medicine) Mrs. Marin has nothing to disclose.
No disclosure on file
No disclosure on file
Andrew E. Budson, MD (VA Boston Healthcare System) Dr. Budson has received personal compensation for serving as an employee of Boston Center for Memory. Dr. Budson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Budson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Budson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Budson has received research support from Department of Veterans Affairs. The institution of Dr. Budson has received research support from NIH. The institution of Dr. Budson has received research support from Bristol Myers Squibb. The institution of Dr. Budson has received research support from VoxNeuro. The institution of Dr. Budson has received research support from Eisai. Dr. Budson has received publishing royalties from a publication relating to health care. Dr. Budson has received publishing royalties from a publication relating to health care. Dr. Budson has a non-compensated relationship as a Alzheimer's Advisory Panel with Commonwealth of Massachusetts that is relevant to AAN interests or activities.